Humana Inc. (NYSE:HUM) Shares Purchased by Toronto Dominion Bank

Toronto Dominion Bank increased its holdings in shares of Humana Inc. (NYSE:HUM) by 1.3% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 59,992 shares of the insurance provider’s stock after purchasing an additional 754 shares during the quarter. Toronto Dominion Bank’s holdings in Humana were worth $19,002,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC grew its position in Humana by 9.9% in the second quarter. Wealth Enhancement Advisory Services LLC now owns 8,713 shares of the insurance provider’s stock valued at $3,256,000 after acquiring an additional 787 shares in the last quarter. Envestnet Portfolio Solutions Inc. grew its position in Humana by 14.4% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 5,490 shares of the insurance provider’s stock valued at $2,051,000 after acquiring an additional 689 shares in the last quarter. AdvisorNet Financial Inc grew its position in Humana by 18.6% in the second quarter. AdvisorNet Financial Inc now owns 287 shares of the insurance provider’s stock valued at $107,000 after acquiring an additional 45 shares in the last quarter. Blue Trust Inc. grew its position in Humana by 51.7% in the second quarter. Blue Trust Inc. now owns 1,708 shares of the insurance provider’s stock valued at $592,000 after acquiring an additional 582 shares in the last quarter. Finally, Everpar Advisors LLC grew its position in Humana by 34.9% in the second quarter. Everpar Advisors LLC now owns 866 shares of the insurance provider’s stock valued at $324,000 after acquiring an additional 224 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Stock Performance

HUM stock opened at $272.78 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market capitalization of $32.85 billion, a price-to-earnings ratio of 24.16, a PEG ratio of 2.18 and a beta of 0.53. Humana Inc. has a 1 year low of $213.31 and a 1 year high of $488.89. The stock’s fifty day moving average is $272.83 and its two-hundred day moving average is $325.59.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. On average, research analysts predict that Humana Inc. will post 16.14 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio is currently 31.36%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on HUM. Leerink Partnrs downgraded shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. JPMorgan Chase & Co. raised their price target on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 21st. Truist Financial decreased their price target on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a research report on Friday, October 11th. Oppenheimer decreased their price target on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Finally, Wells Fargo & Company decreased their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Twenty research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $304.15.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.